Orient Pharma Co., Ltd. (TPEX: 4166)
Taiwan
· Delayed Price · Currency is TWD 38.95
-0.45 (-1.14%)
Nov 21, 2024, 2:56 PM CST
Orient Pharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 119.1 | 22.29 | -28.76 | -102.65 | -171.38 | -201.03 | Upgrade
|
| Depreciation & Amortization | 135.55 | 134.35 | 66.24 | 60.23 | 61.79 | 63.85 | Upgrade
|
| Other Amortization | 1.34 | 1.22 | 2.86 | 4.95 | 4.78 | 3.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.04 | 0.04 | 0.13 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 10 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 0.14 | 1.98 | 4.64 | Upgrade
|
| Provision & Write-off of Bad Debts | 10.66 | 3.44 | - | - | - | - | Upgrade
|
| Other Operating Activities | 35.24 | 4.94 | 11.15 | -4.12 | 16.76 | 11.09 | Upgrade
|
| Change in Accounts Receivable | -19.6 | -95.37 | -6.31 | 15.12 | -11.03 | -2.41 | Upgrade
|
| Change in Inventory | -77.31 | -43.67 | -62.23 | -25.38 | -36.33 | -27.27 | Upgrade
|
| Change in Accounts Payable | 26.71 | -6.37 | 42.64 | -9.01 | -10.49 | 5.5 | Upgrade
|
| Change in Unearned Revenue | 20.73 | -42.86 | -13.2 | 33.34 | -1.28 | - | Upgrade
|
| Change in Other Net Operating Assets | -81.73 | -80.99 | -1.14 | -36.17 | -2.75 | 12.42 | Upgrade
|
| Operating Cash Flow | 170.73 | -102.99 | 11.38 | -53.57 | -147.95 | -129.91 | Upgrade
|
| Capital Expenditures | -25.61 | -54.11 | -28.4 | -66.54 | -74.43 | -25.4 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.26 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.32 | -19.4 | -0.52 | -3.46 | - | -9.01 | Upgrade
|
| Investment in Securities | -9 | -9 | - | 120 | -120 | 50 | Upgrade
|
| Other Investing Activities | -4.01 | -5.5 | -0.42 | 5.81 | -0.17 | 0.11 | Upgrade
|
| Investing Cash Flow | -38.94 | -88.02 | -29.09 | 55.81 | -194.6 | 15.71 | Upgrade
|
| Short-Term Debt Issued | - | 246 | - | 129.5 | - | 55.5 | Upgrade
|
| Long-Term Debt Issued | - | - | 133 | - | 66 | 68 | Upgrade
|
| Total Debt Issued | 22.5 | 246 | 133 | 129.5 | 66 | 123.5 | Upgrade
|
| Short-Term Debt Repaid | - | - | -93 | - | -23.5 | - | Upgrade
|
| Long-Term Debt Repaid | - | -48.1 | -76.79 | -48.79 | -87.65 | -32.86 | Upgrade
|
| Total Debt Repaid | -93.71 | -48.1 | -169.79 | -48.79 | -111.15 | -32.86 | Upgrade
|
| Net Debt Issued (Repaid) | -71.21 | 197.9 | -36.79 | 80.71 | -45.15 | 90.64 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 400 | 3.92 | Upgrade
|
| Other Financing Activities | - | - | - | -1.6 | - | - | Upgrade
|
| Financing Cash Flow | -71.21 | 197.9 | -36.79 | 79.11 | 354.85 | 94.56 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | - | 0 | -0 | -0.03 | - | Upgrade
|
| Net Cash Flow | 60.58 | 6.89 | -54.49 | 81.34 | 12.27 | -19.64 | Upgrade
|
| Free Cash Flow | 145.12 | -157.1 | -17.01 | -120.1 | -222.38 | -155.3 | Upgrade
|
| Free Cash Flow Margin | 13.62% | -17.65% | -3.32% | -25.92% | -53.97% | -43.93% | Upgrade
|
| Free Cash Flow Per Share | 0.65 | -0.70 | -0.09 | -0.64 | -1.31 | -1.00 | Upgrade
|
| Cash Interest Paid | 14.62 | 13.42 | 7.44 | 5.62 | 5.41 | 5.07 | Upgrade
|
| Cash Income Tax Paid | 2.87 | 0.04 | 1.37 | 3.9 | 0.02 | 0.02 | Upgrade
|
| Levered Free Cash Flow | 76.13 | -188.04 | -11.17 | -101.34 | -160.99 | -93.91 | Upgrade
|
| Unlevered Free Cash Flow | 85.07 | -179.35 | -6.56 | -97.77 | -157.63 | -90.83 | Upgrade
|
| Change in Net Working Capital | 115.91 | 256.61 | 20.66 | 9.66 | 47.52 | -0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.